Log In
Print this Print this

JRC-LAMP-vax vaccine

  Manage Alerts
Collapse Summary General Information
Company Immunomic Therapeutics Inc.
DescriptionPlasmid-based DNA vaccine that uses lysosomal-associated membrane protein (LAMP) antigen targeting sequence to enhance immune response
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat rhinoconjunctivitis symptoms caused by allergic reaction to Japanese red cedar pollen
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today